Pharmaceutical

Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates

Click here to register for May 14 investor webcastCompany plans to file its Earnings Report on May 14, 2024 on…

8 months ago

Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates

Click here to register for May 14 investor webcastCompany plans to file its Earnings Report on May 14, 2024 on…

8 months ago

A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox

NV-387 Possesses Strong Orthopoxvirus Activity Relevant to Both Sexual and Inhalation Modes of Transmission, Says NanoViricides SHELTON, CT / ACCESSWIRE…

8 months ago

Envision Pharma Group Announces the Appointment of Alistair Macdonald to Board of Directors

Alistair Macdonald brings over 30 years of biopharmaceutical and life sciences leadership experience to Envision Pharma Group's Board of DirectorsFAIRFIELD,…

8 months ago

iZafe Group Exhibits at Vitalis 2024 – The Future of Health and Welfare Technology

STOCKHOLM, Sweden / ACCESSWIRE / May 8, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB ("iZafe Group"), in collaboration with…

8 months ago

IRLAB Publishes Interim Eeport for the Period January-March 2024

GOTHENBURG, SWEDEN / ACCESSWIRE / May 8, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 8, 2024 - IRLAB Therapeutics…

8 months ago

Relief Therapeutics Announces New Executive Leadership Team Strengthening Capabilities to Guide the Company through Pipeline Development Initiatives

GENEVA, SWITZERLAND / ACCESSWIRE / May 8, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical…

8 months ago

Protagonist Therapeutics to Participate in the Citizens JMP Life Sciences Conference and the Capital One 1st Annual Biotech/Biopharma Disruptors Event

NEWARK, CA / ACCESSWIRE / May 7, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") (NASDAQ:PTGX) today announced that…

8 months ago